The evolution and the emergence of new mutations of viruses affect their transmissibility
and/or pathogenicity features, depending on different evolutionary scenarios of virus …

SARS-CoV-2 can cause lung diseases, such as pneumonia and acute respiratory distress
syndrome, and multi-system dysfunction. Post-translational modifications (PTMs) related to …

The emergence of new SARS-CoV-2 Omicron variant of concern (OV) has exacerbated the
COVID-19 pandemic because of a large number of mutations in the spike protein …

The glycosylation on the spike (S) protein of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, modulates the viral infection …

COVID-19 has led to over 6.8 million deaths worldwide and continues to affect millions of
people, primarily in low-income countries and communities with low vaccination coverage …

The association of the S-protein of the SARS-CoV-2 beta coronavirus to ACE2 receptors of
the human epithelial cells determines its contagiousness and pathogenicity. We computed …

Abstract On November 24, 2021, the SARS-CoV-2 Omicron variant (B. 1.1. 529) was first
identified in South Africa. The World Health Organization (WHO) declared the Omicron as a …

Introduction The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been classified into variants of interest (VOIs) or concern (VOCs) to prioritize global …

The Coronavirus disease pandemic has steered the global therapeutic research efforts
toward the discovery of potential anti-severe acute respiratory syndrome coronavirus (SARS …

On 26 November 2021, the WHO classified the Omicron variant of the SARS-CoV-2 virus (B.
1.1. 529 lineage) as a variant of concern (VOC)(COVID-19 Variant Data, Department of …